New York Oncology Hematology PC - Rexford

Rexford, New York 12148

0 studies enrolling now · 4 studies all time

What they study most

Clear Cell Renal Cell Carcinoma, Extensive Stage Small Cell Lung Carcinoma, Gastrinoma, Glucagonoma, Insulinoma, Islet Cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Non-small Cell Lung Cancer, Recurrent Small Cell Lung Carcinoma, Somatostatinoma, Stage I Renal Cell Cancer AJCC v6 and v7

Studies at this site

• A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage — Completed
• Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery — Completed
• Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors — Running, not enrolling
• Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer — Completed